Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.

MLA

Miao, Dongmei, et al. “Electrochemiluminescence Assays for Insulin and Glutamic Acid Decarboxylase Autoantibodies Improve Prediction of Type 1 Diabetes Risk.” Diabetes Technology & Therapeutics, vol. 17, no. 2, Feb. 2015, pp. 119–27. EBSCOhost, https://doi.org/10.1089/dia.2014.0186.

APA

Miao, D., Steck, A. K., Zhang, L., Guyer, K. M., Jiang, L., Armstrong, T., Muller, S. M., Krischer, J., Rewers, M., & Yu, L. (2015). Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk. Diabetes Technology & Therapeutics, 17(2), 119–127. https://doi.org/10.1089/dia.2014.0186

Chicago

Miao, Dongmei, Andrea K Steck, Li Zhang, K Michelle Guyer, Ling Jiang, Taylor Armstrong, Sarah M Muller, Jeffrey Krischer, Marian Rewers, and Liping Yu. 2015. “Electrochemiluminescence Assays for Insulin and Glutamic Acid Decarboxylase Autoantibodies Improve Prediction of Type 1 Diabetes Risk.” Diabetes Technology & Therapeutics 17 (2): 119–27. doi:10.1089/dia.2014.0186.